AIDS vaccine trial begins in UgandaBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7386.414/c (Published 22 February 2003) Cite this as: BMJ 2003;326:414
- Susan Mayor
Researchers working at the Uganda Virus Research Institute have begun a trial of an AIDS vaccine with the aim of vaccinating 50 volunteers not infected with HIV, it was announced last week.
The vaccine has been developed to prevent infection with the A strain of HIV, the subtype that is prevalent in Uganda and other parts of east Africa. It represents a major step forward in efforts to prevent the spread of AIDS in Africa, as other vaccines currently being investigated are designed to combat the B strain of HIV, found in the United States and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial